Delivery Order SPE2DB20D3103-SPE2DB23FM6F9
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $3,357.12 firm fixed price delivery order is for the supply of AmBisome 50 mg vials, a specialty pharmaceutical product. The award is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA, serving as the primary vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $2,517.84 firm fixed price delivery order is for the supply of AMBISOME 50 MG VIALS, a specialized pharmaceutical product. This award is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that enables Amerisourcebergen...
- This federal contract award is for the delivery of AMBISOME 50 MG VIALS to the Defense Logistics Agency (DLA). The $1,923.48 firm fixed price delivery order was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., which serves as the primary vehicle for the company to supply a comprehensive range...
- This federal contract award to Amerisourcebergen Drug Corp (Amerisourcebergen), a subsidiary of Amerisourcebergen Corporation, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $5,723.72, is a firm fixed price delivery order for the pharmaceutical product AMBISOME 50 MG VIALS. The contract has an ultimate completion date of April 2, 2024. Amerisourcebergen, as the prime contractor, will deliver the pharmaceutical product to support military treatment...
- This federal contract award, valued at $42,627.76, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $1,975.20 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4559476979 AMBISOME 50 MG VIALS. This contract has an ultimate completion date of January 3, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products...
- Amerisourcebergen Drug Corp, through its Corporate Office division in Conshohocken, Pennsylvania, has been awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical in the amount of $2,517.84. This contract is for the delivery of 50 mg vials of AmBisome, a specialty pharmaceutical product. The contract has a completion date of February 16, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor providing...
- This federal contract award is for the delivery of AmBisome 50 mg vials, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,923.48 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., holds with the DLA Troop...
- This federal contract award is for the delivery of AMBISOME 50 MG VIALS to the Defense Logistics Agency (DLA) Troop Support Medical. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. This is a firm fixed price delivery order contract with a ceiling value of $2,709.48 and a performance period through April 2, 2024. Amerisourcebergen Drug Corp also holds an indefinite delivery contract (IDC) with DLA valued at up...
- This federal contract award is for the delivery of AMBISOME 50 MG VIALS, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The award was made to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is a firm fixed price delivery order with a ceiling value of $7,505.33 and a period of performance through April 11, 2024. No...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB23FM6F9Delivery Order
This federal contract award, with ID SPE2DB20D3103|SPE2DB23FM6F9, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,923.48 firm fixed-price delivery order covers the supply of AmBisome 50 mg vials, a specialty medication. The contract has an ultimate completion date of March 2, 2023 and was awarded on March 1, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is registered in the System for Award Management (SAM.gov) and operates as a for-profit organization. The contract award is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 3/1/23 |